Veterinary Biologics Market Opportunities, Business Forecast To 2030
The report "Veterinary Biologics Market by Product Type (Vaccines, Diagnostic Kits, Antibody Products, Others), by Disease (Bluetongue, Aujeszky's Disease, Bovine Viral Diarrhea, Bovine Tuberculosis, Clostridial Disease, Foot and Mouth Disease, Others), by Species (Poultry, Bovine, Aquatic, Porcine, Others) - Global Forecasts to 2030" The global Veterinary Biologics Market is projected to reach USD 11.2 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=21948 Competitive Dashboard: The prominent key players operating in the global Veterinary Biologics Market are Zoetis, Inc. (U.S.) ElancoAnimal Health (Eli Lilly and Company) (U.S.) Merial (C.H. BoehringerSohn AG & Co. KG) (Germany) Merck & Co., Inc. (U.S.) Bayer AG (Germany) CevaSanteAnimale S.A. (France) Virbac (France) Regional Overview: The...